Paper36975518
The Insulin Receptor Substrate 2 Mediates the Action of Insulin on HeLa Cell Migration via the PI3K/Akt Signaling Pathway.
Martínez Báez A and 4 others. Curr Issues Mol Biol, 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. The Insulin Receptor Substrate 2 Mediates the Action of Insulin on HeLa Cell Migration via the PI3K/Akt Signaling Pathway. Papers, record 36975518. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36975518
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Insulin Receptor Substrate 2 Mediates the Action of Insulin on HeLa Cell Migration via the PI3K/Akt Signaling Pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CB-2011-168375-B | Consejo Nacional de Ciencia y Tecnología | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2684393 | Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. | Cancer Res | 1989 | https://conductscience.org/library/papers/2684393 | PubMed |
| 2 | 22664743 | Downregulation of IRS-1 promotes metastasis of head and neck squamous cell carcinoma. | Oncol Rep | 2012 | https://conductscience.org/library/papers/22664743 | PubMed |
| 3 | 33393497 | Insulin signaling in health and disease. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33393497 | PubMed |
| 4 | 1311924 | Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma. | Biochem Biophys Res Commun | 1992 | https://conductscience.org/library/papers/1311924 | PubMed |
| 5 | 34443299 | Insulin Receptor Substrate 1 Is Involved in the Phycocyanin-Mediated Antineoplastic Function of Non-Small Cell Lung Cancer Cells. | Molecules | 2021 | https://conductscience.org/library/papers/34443299 | PubMed |
| 6 | 36479179 | Resveratrol Inhibits Insulin-Induced Vascular Smooth Muscle Cell Proliferation and Migration by Activating SIRT1. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/36479179 | PubMed |
| 7 | 31393907 | Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC). | PLoS One | 2019 | https://conductscience.org/library/papers/31393907 | PubMed |
| 8 | 14712218 | Insulin-like growth factor-I signaling in human neuroblastoma cells. | Oncogene | 2004 | https://conductscience.org/library/papers/14712218 | PubMed |
| 9 | 17361103 | Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. | Cell Cycle | 2007 | https://conductscience.org/library/papers/17361103 | PubMed |
| 10 | 17332342 | Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells. | Cancer Res | 2007 | https://conductscience.org/library/papers/17332342 | PubMed |
| 11 | 11704861 | Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. | Oncogene | 2001 | https://conductscience.org/library/papers/11704861 | PubMed |
| 12 | 16707456 | Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration. | Cancer Res | 2006 | https://conductscience.org/library/papers/16707456 | PubMed |
| 13 | 17071576 | The metabolic syndrome: A high-risk state for cancer? | Am J Pathol | 2006 | https://conductscience.org/library/papers/17071576 | PubMed |
| 14 | 29400692 | Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer. | J Clin Invest | 2018 | https://conductscience.org/library/papers/29400692 | PubMed |
| 15 | 15917419 | Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. | J Clin Pathol | 2005 | https://conductscience.org/library/papers/15917419 | PubMed |
| 16 | 18711691 | Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines. | Horm Metab Res | 2008 | https://conductscience.org/library/papers/18711691 | PubMed |
| 17 | 10851068 | IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation. | Oncogene | 2000 | https://conductscience.org/library/papers/10851068 | PubMed |
| 18 | 15509777 | Involvement of insulin receptor substrate 2 in mammary tumor metastasis. | Mol Cell Biol | 2004 | https://conductscience.org/library/papers/15509777 | PubMed |
| 19 | 17113337 | Insulin-like growth factors control cell migration in health and disease. | Int J Biochem Cell Biol | 2007 | https://conductscience.org/library/papers/17113337 | PubMed |
| 20 | 14997047 | Motility response to insulin-like growth factor-I (IGF-I) in MCF-7 cells is associated with IRS-2 activation and integrin expression. | Breast Cancer Res Treat | 2004 | https://conductscience.org/library/papers/14997047 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41832547 | Antiproliferative activity, phytochemistry, network pharmacology, molecular docking and gene expression analysis of Maerua edulis extracts against human cervical cancer cell line. | BMC Complement Med Ther | 2026 | https://conductscience.org/library/papers/41832547 | PubMed |
| 41575664 | IRS2 as a driver and therapeutic target in brain metastases from colorectal cancer: a systematic review of mechanistic and translational evidence. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41575664 | PubMed |
| 41097225 | Effects of Nicotinamide Mononucleotide Supplementation and Aerobic Exercise on Metabolic Health and Physical Performance in Aged Mice. | Nutrients | 2025 | https://conductscience.org/library/papers/41097225 | PubMed |
| 40740995 | Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40740995 | PubMed |
| 40574003 | pH-Responsive Liposome-Hydrogel Composite Accelerates Nasal Mucosa Wound Healing. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40574003 | PubMed |
| 39085196 | Gingipain from Porphyromonas gingivalis causes insulin resistance by degrading insulin receptors through direct proteolytic effects. | Int J Oral Sci | 2024 | https://conductscience.org/library/papers/39085196 | PubMed |
| 39005932 | Phytochemical analysis, in-vitro and in-silico study of antiproliferative activity of ethyl acetate fraction of Launaea cornuta (Hochst. ex Oliv. & Hiern) C. Jeffrey against human cervical cancer cell line. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39005932 | PubMed |
| 38952983 | ULK2 suppresses ovarian cancer cell migration and invasion by elevating IGFBP3. | PeerJ | 2024 | https://conductscience.org/library/papers/38952983 | PubMed |
| 38396649 | Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396649 | PubMed |
| 37596643 | PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37596643 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36975518
GET https://conductscience.org/api/papers/v1/36975518/references?page=2